311 related articles for article (PubMed ID: 31686407)
21. Association of Vitamin D Levels With Multiple Sclerosis Activity and Progression in Patients Receiving Interferon Beta-1b.
Fitzgerald KC; Munger KL; Köchert K; Arnason BG; Comi G; Cook S; Goodin DS; Filippi M; Hartung HP; Jeffery DR; O'Connor P; Suarez G; Sandbrink R; Kappos L; Pohl C; Ascherio A
JAMA Neurol; 2015 Dec; 72(12):1458-65. PubMed ID: 26458124
[TBL] [Abstract][Full Text] [Related]
22. Early treatment responses to peginterferon beta-1a are associated with longer-term clinical outcomes in patients with relapsing-remitting multiple sclerosis: Subgroup analyses of ADVANCE and ATTAIN.
Newsome SD; Scott TF; Arnold DL; Altincatal A; Naylor ML
Mult Scler Relat Disord; 2022 Jan; 57():103367. PubMed ID: 35158473
[TBL] [Abstract][Full Text] [Related]
23. A longitudinal study of serum 25-hydroxyvitamin D and intact parathyroid hormone levels indicate the importance of vitamin D and calcium homeostasis regulation in multiple sclerosis.
Soilu-Hänninen M; Laaksonen M; Laitinen I; Erälinna JP; Lilius EM; Mononen I
J Neurol Neurosurg Psychiatry; 2008 Feb; 79(2):152-7. PubMed ID: 17578859
[TBL] [Abstract][Full Text] [Related]
24. A Brief Review of the Effects of Vitamin D on Multiple Sclerosis.
Miclea A; Bagnoud M; Chan A; Hoepner R
Front Immunol; 2020; 11():781. PubMed ID: 32435244
[TBL] [Abstract][Full Text] [Related]
25. A randomised, double blind, placebo controlled trial with vitamin D3 as an add on treatment to interferon β-1b in patients with multiple sclerosis.
Soilu-Hänninen M; Aivo J; Lindström BM; Elovaara I; Sumelahti ML; Färkkilä M; Tienari P; Atula S; Sarasoja T; Herrala L; Keskinarkaus I; Kruger J; Kallio T; Rocca MA; Filippi M
J Neurol Neurosurg Psychiatry; 2012 May; 83(5):565-71. PubMed ID: 22362918
[TBL] [Abstract][Full Text] [Related]
26. Interferons-beta versus glatiramer acetate for relapsing-remitting multiple sclerosis.
La Mantia L; Di Pietrantonj C; Rovaris M; Rigon G; Frau S; Berardo F; Gandini A; Longobardi A; Weinstock-Guttman B; Vaona A
Cochrane Database Syst Rev; 2016 Nov; 11(11):CD009333. PubMed ID: 27880972
[TBL] [Abstract][Full Text] [Related]
27. Safety and T cell modulating effects of high dose vitamin D3 supplementation in multiple sclerosis.
Smolders J; Peelen E; Thewissen M; Cohen Tervaert JW; Menheere P; Hupperts R; Damoiseaux J
PLoS One; 2010 Dec; 5(12):e15235. PubMed ID: 21179201
[TBL] [Abstract][Full Text] [Related]
28. Vitamin D supplementation and monitoring in multiple sclerosis: who, when and wherefore.
Holmøy T; Torkildsen Ø; Myhr KM; Løken-Amsrud KI
Acta Neurol Scand Suppl; 2012; (195):63-9. PubMed ID: 23278659
[TBL] [Abstract][Full Text] [Related]
29. Immunomodulators and immunosuppressants for multiple sclerosis: a network meta-analysis.
Filippini G; Del Giovane C; Vacchi L; D'Amico R; Di Pietrantonj C; Beecher D; Salanti G
Cochrane Database Syst Rev; 2013 Jun; (6):CD008933. PubMed ID: 23744561
[TBL] [Abstract][Full Text] [Related]
30. Vitamin D as an early predictor of multiple sclerosis activity and progression.
Ascherio A; Munger KL; White R; Köchert K; Simon KC; Polman CH; Freedman MS; Hartung HP; Miller DH; Montalbán X; Edan G; Barkhof F; Pleimes D; Radü EW; Sandbrink R; Kappos L; Pohl C
JAMA Neurol; 2014 Mar; 71(3):306-14. PubMed ID: 24445558
[TBL] [Abstract][Full Text] [Related]
31. Vitamin D supplementation to prevent acute respiratory infections: a systematic review and meta-analysis of aggregate data from randomised controlled trials.
Jolliffe DA; Camargo CA; Sluyter JD; Aglipay M; Aloia JF; Ganmaa D; Bergman P; Bischoff-Ferrari HA; Borzutzky A; Damsgaard CT; Dubnov-Raz G; Esposito S; Gilham C; Ginde AA; Golan-Tripto I; Goodall EC; Grant CC; Griffiths CJ; Hibbs AM; Janssens W; Khadilkar AV; Laaksi I; Lee MT; Loeb M; Maguire JL; Majak P; Mauger DT; Manaseki-Holland S; Murdoch DR; Nakashima A; Neale RE; Pham H; Rake C; Rees JR; Rosendahl J; Scragg R; Shah D; Shimizu Y; Simpson-Yap S; Trilok-Kumar G; Urashima M; Martineau AR
Lancet Diabetes Endocrinol; 2021 May; 9(5):276-292. PubMed ID: 33798465
[TBL] [Abstract][Full Text] [Related]
32. Vitamin D supplementation for prevention of mortality in adults.
Bjelakovic G; Gluud LL; Nikolova D; Whitfield K; Wetterslev J; Simonetti RG; Bjelakovic M; Gluud C
Cochrane Database Syst Rev; 2014 Jan; (1):CD007470. PubMed ID: 24414552
[TBL] [Abstract][Full Text] [Related]
33. Vitamin D supplementation for sickle cell disease.
Soe HH; Abas AB; Than NN; Ni H; Singh J; Said AR; Osunkwo I
Cochrane Database Syst Rev; 2017 Jan; 1(1):CD010858. PubMed ID: 28105733
[TBL] [Abstract][Full Text] [Related]
34. Safety of vitamin D3 in adults with multiple sclerosis.
Kimball SM; Ursell MR; O'Connor P; Vieth R
Am J Clin Nutr; 2007 Sep; 86(3):645-51. PubMed ID: 17823429
[TBL] [Abstract][Full Text] [Related]
35. Vitamin D supplementation and prevention of cardiovascular disease and cancer in the Finnish Vitamin D Trial: a randomized controlled trial.
Virtanen JK; Nurmi T; Aro A; Bertone-Johnson ER; Hyppönen E; Kröger H; Lamberg-Allardt C; Manson JE; Mursu J; Mäntyselkä P; Suominen S; Uusitupa M; Voutilainen A; Tuomainen TP; Hantunen S
Am J Clin Nutr; 2022 May; 115(5):1300-1310. PubMed ID: 34982819
[TBL] [Abstract][Full Text] [Related]
36. Efficacy of vitamin D supplementation in multiple sclerosis (EVIDIMS Trial): study protocol for a randomized controlled trial.
Dörr J; Ohlraun S; Skarabis H; Paul F
Trials; 2012 Feb; 13():15. PubMed ID: 22316314
[TBL] [Abstract][Full Text] [Related]
37. Effect of interferon beta-1a subcutaneously three times weekly on clinical and radiological measures and no evidence of disease activity status in patients with relapsing-remitting multiple sclerosis at year 1.
Traboulsee A; Li DKB; Cascione M; Fang J; Dangond F; Miller A
BMC Neurol; 2018 Sep; 18(1):143. PubMed ID: 30217172
[TBL] [Abstract][Full Text] [Related]
38. Effect of vitamin D3 supplementation on relapses, disease progression, and measures of function in persons with multiple sclerosis: exploratory outcomes from a double-blind randomised controlled trial.
Kampman MT; Steffensen LH; Mellgren SI; Jørgensen L
Mult Scler; 2012 Aug; 18(8):1144-51. PubMed ID: 22354743
[TBL] [Abstract][Full Text] [Related]
39. Dose-response effects of supplementation with calcifediol on serum 25-hydroxyvitamin D status and its metabolites: A randomized controlled trial in older adults.
Vaes AMM; Tieland M; de Regt MF; Wittwer J; van Loon LJC; de Groot LCPGM
Clin Nutr; 2018 Jun; 37(3):808-814. PubMed ID: 28433267
[TBL] [Abstract][Full Text] [Related]
40. High-dose vitamin D
Cassard SD; Fitzgerald KC; Qian P; Emrich SA; Azevedo CJ; Goodman AD; Sugar EA; Pelletier D; Waubant E; Mowry EM
EClinicalMedicine; 2023 May; 59():101957. PubMed ID: 37125397
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
